Obesity
Not recruitingStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
- Disease:Obesity
- Substances:–
The Netherlands- Participants:18–64 years · 65+ years
- Sponsor:Novo Nordisk A/S
Rare diseases
Investigational molecules
Locations
Back to the Netherlands171 clinical trials in Arnhem, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on advanced gastric cancer, bladder cancer, and various forms of leukemia. Studies include evaluation of novel imaging techniques and combination therapies for better treatment outcomes.
Multiple trials exploring targeted therapies and innovative diagnostic approaches for various cancer types.
Comprehensive studies addressing cardiovascular disease management and prevention, including research on post-stroke care and cardiac arrest treatments.
Focus on improving patient outcomes through innovative therapeutic approaches and prevention strategies.
Clinical investigations targeting obesity and weight management, with emphasis on new therapeutic agents and their cardiovascular safety profiles.
Evaluating novel approaches to treating metabolic disorders and their associated complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.